Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346172 · ClinicalTrials.gov registry record
The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction
A clinical trial, sponsored by Research Insight.
- Completed
- Registry status
- 60
- Enrollment target
NCT05346172 is a clinical trial that has completed, run by Research Insight. The registered enrollment target is 60 participants.
The verdict
NCT05346172 has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.
Interventions
- DEVICE PanOptix or PanOptix Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2023-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05346172
The ClinicalTrials.gov registry entry for NCT05346172 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PanOptix or PanOptix Toric IOL is the first listed.
NCT05346172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05346172 about?
NCT05346172 is a clinical study titled "The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction". This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.
What is the current status of trial NCT05346172?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2022-06-17. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT05346172?
The interventions under investigation include: PanOptix or PanOptix Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT05346172?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.